You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (230)

Journals (0)

1-10 of 230 results for unapproved drugs

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Unapproved Drugs—The Drug Information Pharmacists’ Perspective

Retricted access

Research article

First published 2013-4

Unapproved Drugs—The Drug Information Pharmacists’ Perspective

Mary Giouroukakis, Megan Dryer

Journal of Pharmacy Practice

Select article: Estimating the Impact of Food and Drug Administration’s Unapproved Drug Initiative on Drug Prices and Sales

Retricted access

Research article

First published 2019

Estimating the Impact of Food and Drug Administration’s Unapproved Drug Initiative on Drug Prices and Sales

Dolly Sharma, Glen T. Schumock, Christopher D. Saffore [...]

Therapeutic Innovation & Regulatory Science

Select article: FDA Policy on Unapproved Drug Products: Past,Present,and Future

Retricted access

Research article

First published 2005-7

FDA Policy on Unapproved Drug Products: Past,Present,and Future

Renu Chhabra, Mary E Kremzner, Brenda J Kiliany

Annals of Pharmacotherapy

Select article: Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs

Retricted access

Research article

First published 2016-7

Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs

Barbara K. Redman, Alison Shea Bateman-House

Therapeutic Innovation & Regulatory Science

Select article: Withholding Information on Unapproved Drug Marketing Applications: The Public Has a Right to Know

Retricted access

Research article

First published 2017-12

Withholding Information on Unapproved Drug Marketing Applications: The Public Has a Right to Know

Sammy Almashat, Michael Carome

The Journal of Law,Medicine & Ethics

Select article: Unapproved Drug Therapies

Retricted access

Research article

First published 1988-5

Unapproved Drug Therapies

Greg S. Umstead

Journal of Pharmacy Technology

Select article: Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan

Retricted access

Research article

First published 2017-9

Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan

Tomohisa Sudo, Akihiro Sato

Therapeutic Innovation & Regulatory Science

Select article: The Legal Status of Unapproved Generic Drugs

Retricted access

Research article

First published 1982-2

The Legal Status of Unapproved Generic Drugs

Richard R. Abood

The Journal of Law,Medicine & Ethics

Select article: A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)

Retricted access

Research article

First published 2019-3

A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)

Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher [...]

Therapeutic Innovation & Regulatory Science

Select article: FDA Revises Procedures for Response to Unapprovable NDAs/ New Office for Cancer Drugs at FDA/ Several Countries Take Action on Human Cloning

Retricted access

Research article

First published 2004-10

FDA Revises Procedures for Response to Unapprovable NDAs/ New Office for Cancer Drugs at FDA/ Several Countries Take Action on Human Cloning

Biotechnology Law Report

1
2
3
•••
23
10 / page

Article type

Publication date

Subjects

Access